EEF1B2
Elongation factor 1-beta
Also known as: EF1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24534
- Gene
- EEF1B2
- Ensembl
- ENSG00000114942
- Chromosome
- 2
- Canonical length
- 225 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
This gene encodes a translation elongation factor. The protein is a guanine nucleotide exchange factor involved in the transfer of aminoacylated tRNAs to the ribosome. Alternative splicing results in three transcript variants which differ only in the 5' UTR. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>P24534|EEF1B2
1 MGFGDLKSPA GLQVLNDYLA DKSYIEGYVP SQADVAVFEA VSSPPPADLC HALRWYNHIK
61 SYEKEKASLP GVKKALGKYG PADVEDTTGS GATDSKDDDD IDLFGSDDEE ESEEAKRLRE
121 ERLAQYESKK AKKPALVAKS SILLDVKPWD DETDMAKLEE CVRSIQADGL VWGSSKLVPV
181 GYGIKKLQIQ CVVEDDKVGT DMLEEQITAF EDYVQSMDVA AFNKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against EEF1B2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 1,748 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 1,748 nTPM
- skeletal muscle: 1,163 nTPM
- ovary: 909 nTPM
- esophagus: 857 nTPM
- skin: 855 nTPM
- cervix: 678 nTPM
Single-cell type
- esophageal suprabasal cells: 3,043 nCPM
- esophageal basal cells: 2,359 nCPM
- pancreatic acinar cells: 2,272 nCPM
- esophageal apical cells: 2,014 nCPM
- enteric stem cells: 1,888 nCPM
- enteric transient amplifying cells: 1,728 nCPM
Immune cell
- total PBMC: 1,772 nTPM
- memory B-cell: 1,080 nTPM
- naive CD4 T-cell: 1,079 nTPM
- naive CD8 T-cell: 901 nTPM
- naive B-cell: 853 nTPM
- MAIT T-cell: 796 nTPM
Brain region
- choroid plexus: 193 nTPM
- spinal cord: 102 nTPM
- white matter: 93 nTPM
- basal ganglia: 91 nTPM
- medulla oblongata: 90 nTPM
- thalamus: 88 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EEF1B2.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 40 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- -0.85
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translation elongation factor EF1B, beta/delta chains, conserved site
- Translation elongation factor EF1B, beta/delta subunit, guanine nucleotide exchange domain
- Translation elongation factor EF1B/small ribosomal subunit protein bS6
- Elongation factor 1 beta central acidic region, eukaryote
- Translation elongation factor eEF-1beta-like superfamily
- Glutathione S-transferase, C-terminal domain superfamily
- Translation elongation factor EF1B, beta/delta subunit
- EF-1 guanine nucleotide exchange domain
- Eukaryotic elongation factor 1 beta central acidic region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EEF1B2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EEF1B2 as an antibody target. Whether an autoantibody or antibody against EEF1B2 could matter depends on whether native EEF1B2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EEF1B2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EEF1B2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...